Swiss biotech company Novimmune (IPO-NOVI.S), seen as a potential IPO candidate, said on Wednesday it has appointed former Actelion CFO Andrew J. Oakley as its new finance chief.
Oakley, a UK and Australian citizen who was CFO of Actelion for a decade, stepped down from the company last August to focus on other opportunities.
Help employers find you! Check out all the jobs and post your resume.
